Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a small molecule belonging to the class of dihydrothiophenes. It is structurally characterized by a thiophene ring with hydroxyl and methyl substituents and an E-configured butadiene side chain at the chiral center. The compound has been studied in experimental contexts and appears in protein-ligand databases such as PDB under the code name TL6[2][4][8]. There is no evidence of clinical use or marketed product for this specific compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (5r)-5-[(1e)-buta-1,3-dienyl]-4-hydroxy-3,5-dimethylthiophen-2(5h)-one.